MFMichael J. Fink

Michael J. Fink

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael J. Fink has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enlightening the Path to Protein Engineering: Chemoselective Turn-On Probes for High-Throughput Screening of Enzymatic Activity

    by Sebastian Hecko, Astrid Schiefer, Christoffel P. S. Badenhorst, Michael J. Fink, Marko D. Mihovilovic, Uwe T. Bornscheuer, Florian Rudroff

    Many successful stories in enzyme engineering are based on the creation of randomized diversity in large mutant libraries, containing millions to billions of enzyme variants. Methods that enabled their evaluation with high throughput are dominated by spectroscopic techniques due to their high speed and sensitivity. A large proportion of studies relies on fluorogenic substrates that mimic the chemical properties of the target or coupled enzymatic assays with an optical read-out that assesses the desired catalytic efficiency indirectly. The most reliable hits, however, are achieved by screening for conversions of the starting material to the desired product. For this purpose, functional group assays offer a general approach to achieve a fast, optical read-out. They use the chemoselectivity, differences in electronic and steric properties of various functional groups, to reduce the number of false-positive results and the analytical noise stemming from enzymatic background activities. This review summarizes the developments and use of functional group probes for chemoselective derivatizations, with a clear focus on screening for enzymatic activity in protein engineering.


  • Open Access

    Storing and Reading Information in Mixtures of Fluorescent Molecules

    by Amit A. Nagarkar, Samuel E. Root, Michael J. Fink, Alexei S. Ten, Brian J. Cafferty, Douglas S. Richardson, Milan Mrksich, George M. Whitesides


  • Open Access

    A click-flipped enzyme substrate boosts the performance of the diagnostic screening for Hunter syndrome

    by Markus Schwarz, Philipp Skrinjar, Michael J. Fink, Stefan Kronister, Thomas Mechtler, Panagiotis I. Koukos, Alexandre M. J. J. Bonvin, David C. Kasper, Hannes Mikula

    We report on the unexpected finding that click modification of iduronyl azides results in a conformational flip of the pyranose ring, which led to the development of a new strategy for the design of superior enzyme substrates for the diagnostic assaying of iduronate-2-sulfatase (I2S), a lysosomal enzyme related to Hunter syndrome. Synthetic substrates are essential in testing newborns for metabolic disorders to enable early initiation of therapy. Our click-flipped iduronyl triazole showed a remarkably better performance with I2S than commonly used O-iduronates. We found that both O- and triazole-linked substrates are accepted by the enzyme, irrespective of their different conformations, but only the O-linked product inhibits the activity of I2S. Thus, in the long reaction times required for clinical assays, the triazole substrate substantially outperforms the O-iduronate. Applying our click-flipped substrate to assay I2S in dried blood spots sampled from affected patients and random newborns significantly increased the confidence in discriminating between these groups, clearly indicating the potential of the click-flip strategy to control the biomolecular function of carbohydrates.


  • Open Access

    A Click-Flipped Enzyme Substrate Boosts the Performance of the Diagnostic Screening for Hunter Syndrome

    by Markus Schwarz, Philipp Skrinjar, Michael J. Fink, Stefan Kronister, Thomas Mechtler, Panagiotis Koukos, Alexandre M.J.J. Bonvin, David Kasper, Hannes Mikula

    We report on the unexpected finding that click modification of iduronyl azides results in a conformational flip of the pyranose ring, which led to the development of a new strategy for the design of superior enzyme substrates for the diagnostic assaying of iduronate-2-sulfatase (I2S), a lysosomal enzyme related to Hunter syndrome. Synthetic substrates are essential in testing newborns for metabolic disorders to enable early initiation of therapy. Our click-flipped iduronyl triazole showed a remarkably better performance with I2S than commonly used O-iduronates. We found that both O- and triazole-linked substrates are accepted by the enzyme, irrespective of their different conformations, but only the O-linked product inhibits the activity of I2S. Thus, in the long reaction times required for clinical assays, the triazole substrate substantially outperforms the O-iduronate. Applying our click-flipped substrate to assay I2S in dried blood spots sampled from affected patients and random newborns significantly increased the confidence in discriminating between these groups, clearly indicating the potential of the click-flip strategy to control the biomolecular function of carbohydrates.

  • Open Access

    Back Cover: Analysis of Powders Containing Illicit Drugs Using Magnetic Levitation (Angew. Chem. Int. Ed. 2/2020)

    by Christoffer K. Abrahamsson, Amit Nagarkar, Michael J. Fink, Daniel J. Preston, Shencheng Ge, Joseph S. Bozenko, George M. Whitesides

  • Open Access

    Rücktitelbild: Analysis of Powders Containing Illicit Drugs Using Magnetic Levitation (Angew. Chem. 2/2020)

    by Christoffer K. Abrahamsson, Amit Nagarkar, Michael J. Fink, Daniel J. Preston, Shencheng Ge, Joseph S. Bozenko, George M. Whitesides

  • Analysis of Powders Containing Illicit Drugs Using Magnetic Levitation

    by Christoffer K. Abrahamsson, Amit Nagarkar, Michael J. Fink, Daniel J. Preston, Shencheng Ge, Joseph S. Bozenko, George M. Whitesides

    Magneto‐Archimedes levitation (MagLev) enables the separation of powdered mixtures of illicit drugs (cocaine, methamphetamine, heroin, fentanyl, and its analogues), adulterants, and diluents based on density, and allows the presumptive identification of individual components. Small samples (mass <50 mg), with low concentrations of illicit drugs, present a particular challenge to analysis for forensic chemists. The MagLev device, a cuvette containing a solution of paramagnetic gadolinium(III) chelate in a non‐polar solvent, placed between two like‐poles‐facing NdFeB magnets, allowed separation of seven relevant compounds simultaneously. In particular, initial separation with MagLev, followed by characterization by FTIR‐ATR, enabled identification of fentanyl in a sample of fentanyl‐laced heroin (1.3 wt % fentanyl, 2.6 wt % heroin, and 96.1 wt % lactose). MagLev allows identification of unknown powders in mixtures and enables confirmatory identification based on structure‐specific techniques.


  • Analysis of Powders Containing Illicit Drugs Using Magnetic Levitation

    by Christoffer K. Abrahamsson, Amit Nagarkar, Michael J. Fink, Daniel J. Preston, Shencheng Ge, Joseph S. Bozenko, George M. Whitesides

    Magneto‐Archimedes levitation (MagLev) enables the separation of powdered mixtures of illicit drugs (cocaine, methamphetamine, heroin, fentanyl, and its analogues), adulterants, and diluents based on density, and allows the presumptive identification of individual components. Small samples (mass <50 mg), with low concentrations of illicit drugs, present a particular challenge to analysis for forensic chemists. The MagLev device, a cuvette containing a solution of paramagnetic gadolinium(III) chelate in a non‐polar solvent, placed between two like‐poles‐facing NdFeB magnets, allowed separation of seven relevant compounds simultaneously. In particular, initial separation with MagLev, followed by characterization by FTIR‐ATR, enabled identification of fentanyl in a sample of fentanyl‐laced heroin (1.3 wt % fentanyl, 2.6 wt % heroin, and 96.1 wt % lactose). MagLev allows identification of unknown powders in mixtures and enables confirmatory identification based on structure‐specific techniques.


  • Open Access

    Storage of Information Using Small Organic Molecules

    by Brian J. Cafferty, Alexei S. Ten, Michael J. Fink, Scott Morey, Daniel J. Preston, Milan Mrksich, George M. Whitesides

    Although information is ubiquitous, and its technology arguably among the highest that humankind has produced, its very ubiquity has posed new types of problems. Three that involve storage of information (rather than computation) include its usage of energy, the robustness of stored information over long times, and its ability to resist corruption through tampering. The difficulty in solving these problems using present methods has stimulated interest in the possibilities available through fundamentally different strategies, including storage of information in molecules. Here we show that storage of information in mixtures of readily available, stable, low-molecular-weight molecules offers new approaches to this problem. This procedure uses a common, small set of molecules (here, 32 oligopeptides) to write binary information. It minimizes the time and difficulty of synthesis of new molecules. It also circumvents the challenges of encoding and reading messages in linear macromolecules. We have encoded, written, stored, and read a total of approximately 400 kilobits (both text and images), coded as mixtures of molecules, with greater than 99% recovery of information, written at an average rate of 8 bits/s, and read at a rate of 20 bits/s. This demonstration indicates that organic and analytical chemistry offer many new strategies and capabilities to problems in long-term, zero-energy, robust information storage.


  • Top Cited Papers
    Open Access

    The Molecular Origin of Enthalpy/Entropy Compensation in Biomolecular Recognition

    by Jerome M. Fox, Mengxia Zhao, Michael J. Fink, Kyungtae Kang, George M. Whitesides

    Biomolecular recognition can be stubborn; changes in the structures of associating molecules, or the environments in which they associate, often yield compensating changes in enthalpies and entropies of binding and no net change in affinities. This phenomenon—termed enthalpy/entropy (H/S) compensation—hinders efforts in biomolecular design, and its incidence—often a surprise to experimentalists—makes interactions between biomolecules difficult to predict. Although characterizing H/S compensation requires experimental care, it is unquestionably a real phenomenon that has, from an engineering perspective, useful physical origins. Studying H/S compensation can help illuminate the still-murky roles of water and dynamics in biomolecular recognition and self-assembly. This review summarizes known sources of H/ S compensation (real and perceived) and lays out a conceptual framework for understanding and dissecting—and, perhaps, avoiding or exploiting—this phenomenon in biophysical systems.